HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and evaluation of N-phenyl-(2-aminothiazol-4-yl)acetamides with phenoxypropanolamine moiety as selective β3-adrenergic receptor agonists.

Abstract
In the search for potent and selective human β3-adrenergic receptor (AR) agonists as potential drugs for use in treating obesity and non-insulin dependent (type 2) diabetes, a series of N-phenyl-(2-aminothiazol-4-yl)acetamides with phenoxypropanolamine moiety were prepared and their biological activities against human β3-, β2-, and β1-ARs were evaluated. Among these compounds, N-phenyl-(2-phenylaminothiazol-4-yl)acetamide (4 g), N-phenyl-(2-benzylaminothiazol-4-yl)acetamide (4j), and N-phenyl-[2-(3-methoxyphenyl)aminothiazol-4-yl]acetamide (6g) derivatives showed potent agonistic activity against the β3-AR with functional selectivity over the β1- and β2-ARs. In addition, these compounds exhibited significant hypoglycemic activity in a rodent model of diabetes.
AuthorsTatsuya Maruyama, Kenichi Onda, Takayuki Suzuki, Masahiko Hayakawa, Takumi Takahashi, Tetsuo Matsui, Toshiyuki Takasu, Itsuro Nagase, Mitsuaki Ohta
JournalChemical & pharmaceutical bulletin (Chem Pharm Bull (Tokyo)) Vol. 60 Issue 5 Pg. 647-58 ( 2012) ISSN: 1347-5223 [Electronic] Japan
PMID22689403 (Publication Type: Journal Article)
Chemical References
  • Acetamides
  • Adrenergic beta-3 Receptor Agonists
  • Hypoglycemic Agents
  • Phenoxypropanolamines
  • Receptors, Adrenergic, beta-1
  • Receptors, Adrenergic, beta-2
  • Receptors, Adrenergic, beta-3
Topics
  • Acetamides (chemistry)
  • Administration, Oral
  • Adrenergic beta-3 Receptor Agonists (chemical synthesis, chemistry, therapeutic use)
  • Animals
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Humans
  • Hypoglycemic Agents (chemical synthesis, chemistry, therapeutic use)
  • Male
  • Mice
  • Obesity (drug therapy)
  • Phenoxypropanolamines (chemistry)
  • Receptors, Adrenergic, beta-1 (chemistry, metabolism)
  • Receptors, Adrenergic, beta-2 (chemistry, metabolism)
  • Receptors, Adrenergic, beta-3 (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: